Team:TecCEM/Study results




I N T E R L A B

Fluorescence measurement



2015 InterLab Protocol


Ligation

Promoters contained in a psB1C3 plasmid were digested with SpeI and PstI. Reagents were added to a 0.5 ml PCR tube in the following order: 12.5 μl of water for molecular biology, 4 μl of NEB® Buffer 2.1, 0.5 μl of BSA, 20 μl of DNA (BioBricks K823005, K823008 and K823013 in pSB1C3 backbone), 1.5 μl of SpeI and 1.5 μl of PstI. The content of the tube was gently mixed, and placed at a Thermoblock at 37°C for 75 minutes. After incubation, the tube was placed at a water bath at 80°C for 20 minutes so that the enzyme could be inactivated. Finally, the digestion product was stored at -20°C.

The GFP cassette, I13504 (contained in a pSB1A2 plasmid) was obtained by digestion with XbaI and PstI. The same procedure was used, but now 20 μl of DNA, 1.5 μl of XbaI enzyme, and 1.5 μl of PstI enzyme were added to the tube. The digestion product was also stored at -20°C.

Then, ligation of the DNA fragments was then performed; since only one possible combination for BioBrick ligation existed (apart from relegation of two backbones) given the sequence of the cohesive ends generated by the restriction enzymes, there was no need to previously purify the DNA.

To ligate, 2 μl of water for molecular biology, 2 μl of NEB® T4 Ligase buffer, 8 μl of the first digestion product (BBa_K823005), 4 μl of the second digestion product (BBa_E0240), 5 μl of the third digestion product (psB1C3 backbone), and 1 μl of NEB® T4 Ligase were added to a 0.5 ml PCR tube. The mixture was incubated at 16°C for 24 hours, then inactivated for 10 minutes at 65°C and finally stored at -20°C.


Transformation

DH5α competent cells acquired from New England Biolabs (NEB ®) were transformed with the assembled BioBricks. NEB ®’s transformation protocol (3) was used: 50 μl of competent cells and 5 μl of each previously assembled device were added to microtubes and they were placed on ice for 10 minutes. Samples were submitted to 45 seconds of a 42°C heat shock followed by placing on ice for 5 minutes. After that, 300 μl of SOC medium was added to each tube and they were placed at 37°C and 250 rpm for 30 minutes. 200 μl of each sample were plated into warm, solid LB media with 0.1% v/v of antibiotic (chloramphenicol 35 mg/ml). After 12 hours of incubation at 37°C 300 rpm, a single colony was isolated from each plate and cultured overnight in LB broth with the previously stated concentration of antibiotic.


Plasmid extraction

Miniprep plasmid-DNA extraction was performed. 10 ml of the transformed culture were centrifuged at 13500 rpm for 30 seconds and cells were resuspended in 350 μl of STET buffer. The mixture was transferred to a 1.5 ml microtube, where 5 μl of lysozyme (10 mg/ml) were added. After incubation for 5 minutes, the tubes were transferred to a boiling water bath for 2 minutes in order to inactivate the enzyme. Samples were centrifuged at 13000 rpm for 10 minutes, bacterial pellet was taken out of the liquid using a sterile micropipette, and 10 μl of RNase A (2 mg/ml) were added as well as 100 of μl MB grade water. After incubating for 8 minutes at room temperatura (RT), 75 μl of sodium acetate (3M), and 400 μl of isopropanol were added. The mixture was gently stirred and incubated for 10 minutes at RT. Then, it was centrifuged for 10 minutes at 13000 rpm, the supernatant was discarded, and the pellet was washed 2 times with 1 ml of ethanol 70% v/v. The DNA was resuspended in 200 μl of MB grade water, quantified by spectrophotometry and stored at -20°C.



Verifying the cloning

The results were validated by restriction mapping and DNA sequencing. For the restriction mapping, digestion reaction was performed as follows. Microtubes were filled with H20°BM (6 μl), buffer NEB 2.1 (2 μl), plasmid (10 μl), enzymes XbaI and PstI (1 μl each); the mix was spin 5 minutes and incubated 1 hr at 37°C. Enzymes were inactivated at 80°C 20 minutes and an electrophoresis gel was run, figure is shown below. Several colonies were restricted at least to have biological triplicates.


DNA Sequencing

In order to determine the similarity of theoretical sequences and sequenced DNA of the plasmids built by the team, an alignment was performed with Geneious (Biomatters Limited, 2005-2015). Identities were high, containing GFP and the respective promoters. An exception was plasmid 3 which chromatogram peaks overlapped; this could be due to impurities in the DNA samples or, most probably, because primers were unspecific.


Measuring

We set up biological replicates in triplícate, this was done by measuring the fluorescence from three different colonies containing the same device.

  1. One plate was streaked per device and control, the plates were incubated overnight (18 hrs) at 37 C. As positive control it was used BBa_I20270, a GFP expression device in the pSB1C3 backbone (chloramphenicol resistant). As negative controls we used BBa_R0040 (pTetR in pSB1C3) (an empty vector transformed). Cells were grown in LB Agar supplemented with Chloramphenicol at 35 μg/ml.
  2. Liquid cultured was inoculated with our experimental devices and controls: Device 1: J23101+I13504, Device 2: J23106+I13504, Device 3: J23117+I13504, positive and negative control. Cells were grown in 250 ml smooths flasks. The tubes were oriented in the incubator at 37 C with shaking at 300 rpm for 16-18 hours. The volume was 10 ml of media. OD600 of the overnight cultures were measured and samples were diluted to an OD600 of 0.5, the dilution was calculated and samples were re-measured to be confirm and OD600 of 0.5.


I. Process flowchart



Flow1TecCEM.jpg


The next procedure was performed to obtain the dilutions:

(OD) * (10) = Total OD.
(Total OD) * (V1) = (Dilution: 0.25) (150µL).
Where V1 stands for the volume of culture to be used.
The volume of H2O °MB for each sample will be complementary to 150µL.


After that, the distribution of the samples in the plaques was defined.


Flow2TecCEM.png


II. Graph and analyze data

Graph procedure for three experiments. Three sets of results were obtained from three different instruments. Each set of results were measured by triplicate and each sample used was prepared by triplicate.


First measurement

    A) Al the data has to be captured in order to analyze it. See Annex 1.1.

    • Two blank samples are used because the plaques couldn´t hold all of the samples at once.
    • A, B, C and D stand for Dilutions 0.25, 0.5, 0.75 and 1.

    B) The average and standard deviation are calculated for every strain using data from the three repetitions, each plaque measured three times. See Annex 1.2.

    C) To facilitate the graphical procedure, the average and standard deviation tables are transposed. See Annex 1.3.

    D) The final graph will illustrate the Average Fluorescence values for each series of samples versus the four Optical Densities used as shown below. The calculated standard deviation was also included for each average.


Plot1TecCEM.png
Figure 1. Graph showing the fluorescence values versus their optical densities using the first instrument.




Second measurement

The same protocol was performed but with a different instrument.

    A) Captured data is available in Annex 2.1.

    B) Average and standard deviation calculations are in Annex 2.2.

    C) Transposed tables are in Annex 2.3

    D) Final graph is showed below.


Plot2TecCEM.png
Figure 2. Graph showing the fluorescence values versus their optical densities using the second instrument.




Third measurement

    A) Captured data in Annex 3.1.

    B) Average and standard deviation calculations. Available in Annex 3.2.

    C) Transposed tables are in Annex 3.3.

    D) Final graph is showed below.


Plot3TecCEM.png
Figure 3. Graph showing the fluorescence values versus their optical densities using the third instrument.